Energy-linked pyridine nucleotide reduction: inhibitory effects of hyperbaric oxygen in vitro and in vivo.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D001717:Birds; D001921:Brain / Q000378:metabolism*; D005470:Fluorometry; D006931:Hyperbaric Oxygenation; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008928:Mitochondria / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D009243:NAD / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D010085:Oxidative Phosphorylation; D051381:Rats; D012440:Saccharomyces / Q000378:metabolism
D009243:NAD; D009249:NADP; D000654:Amobarbital